MphasiS in for tough times on high attrition, parent woes

Published on Wed, Nov 30, 2011 at 10:38 |  Source : Moneycontrol.com

Updated at Wed, Nov 30, 2011 at 15:27  

13082 Investors following MphasiS. Share this News with them.
0
0
Share on Tumblr
MphasiS in for tough times on high attrition, parent woes

ALSO READ

Moneycontrol Bureau

MphasiS is set to announce its Q4 results today. A CNBC-TV18 poll expects PAT to decline 10% at Rs 175 crore while rupee revenue growth might see a marginal 3% uptick at Rs 1330 crore.

The company has been one of the weakest stories in the IT space given the tough times that parent HP is going through. It has neither been able to grab any large deals nor does it seem capable of being able to retain the multi-year deals that are up for renewal in FY12. The company seems to be continuously losing share to other Indian offshore vendors. In fact, a report by Motilal Oswal says that Q4 volumes for Mphasis could decline 4% quarter-on-quarter in the HP channel.

MphasiS recently acquired Wyde that brought in about USD 4.5 million, but even that might not be able to offset the slack in volume growth in the HP channel, the report says.

Additionally, MphasiS has also been hit by high attrition of 25%, the highest in the industry. This coupled with low growth makes the targeted margin growth of 15-17% extremely challenging for the company.

The stock now trades at Rs 321.

Padma Venkatraman
padma.venkatraman@network18online.com

  

Trending News

Business News

Tags: MphasiS
Tim Cook speaks candidly about Apple at D10
Did Sebi miss any tricks in Ambani consent order? "Did Sebi miss any tricks in Ambani consent order?"

Oppn gears up to make Bharat bandh a success

Ashwini Kumar Says On CNBC-TV18 Expect India Growth Story To March Forward

The latest earning numbers FIRST on CNBC-TV18
Videos

May 30 2012, 11:18

Result corner: Ajay Bodke`s top bets from across sectors

- in MARKET OUTLOOK

Interviews

May 30 2012, 17:04 | Source: CNBC-TV18

Margins may be hit on one-off items in EBITDA: Sun Pharma  

May 30 2012, 16:32 | Source: CNBC-TV18

Essar announces Rs 175cr deal; to pay-off debts with fund  

Subscribe to

Moneycontrol Newsletters

Moneycontrol.com offers you a choice of various sectoral and other newsletters for FREE!